Fiduciary Financial Services Of The Southwest INC Holding in Cvs Health Corp (CVS) Has Trimmed by $3.17 Million

September 17, 2017 - By Henry Gaston

Investors sentiment decreased to 0.74 in 2016 Q4. Its down 0.24, from 0.98 in 2016Q3. It turned negative, as 135 investors sold CVS shares while 627 reduced holdings. 127 funds opened positions while 440 raised stakes. 830.51 million shares or 0.72% less from 836.58 million shares in 2016Q3 were reported. Advantus Management owns 106,391 shares. Parametric Portfolio Assocs Limited Liability Company holds 3.06 million shares or 0.34% of its portfolio. Mairs And owns 2,879 shares. Hilltop holds 0.07% or 3,004 shares. 46,894 are owned by D L Carlson Grp. Gotham Asset Management accumulated 1.06M shares or 1.07% of the stock. Ig Inv Limited owns 2.00 million shares. Nelson Van Denburg And Campbell Wealth Management Grp Inc invested 0.02% of its portfolio in CVS Health Corp (NYSE:CVS). First Bankshares Of Omaha accumulated 193,394 shares. D E Shaw Com has invested 0.28% of its portfolio in CVS Health Corp (NYSE:CVS). Moreover, Van Eck Associate has 0.08% invested in CVS Health Corp (NYSE:CVS) for 196,409 shares. Moors Cabot holds 0.69% of its portfolio in CVS Health Corp (NYSE:CVS) for 52,766 shares. Horizon Invest Services Limited Liability accumulated 17,512 shares. Blackrock Fund Advisors holds 0.21% or 14.30M shares. Comerica reported 2,960 shares.

Since March 17, 2017, it had 0 buys, and 1 sale for $18.44 million activity. Brennan Troyen A sold $1.88M worth of stock or 23,849 shares. Shares for $479,908 were sold by Boratto Eva C on Friday, March 17.

Fiduciary Financial Services Of The Southwest Inc decreased its stake in Cvs Health Corp (CVS) by 69.19% based on its latest 2016Q4 regulatory filing with the SEC. Fiduciary Financial Services Of The Southwest Inc sold 40,701 shares as the company’s stock declined 4.23% while stock markets rallied. The institutional investor held 18,124 shares of the medical and nursing services company at the end of 2016Q4, valued at $1.43 million, down from 58,825 at the end of the previous reported quarter. Fiduciary Financial Services Of The Southwest Inc who had been investing in Cvs Health Corp for a number of months, seems to be less bullish one the $84.55B market cap company. The stock increased 0.64% or $0.53 on September 15, reaching $83.17. About 7.48M shares traded or 46.09% up from the average. CVS Health Corp (NYSE:CVS) has declined 24.40% since September 17, 2016 and is downtrending. It has underperformed by 41.10% the S&P500.

Fiduciary Financial Services Of The Southwest Inc, which manages about $377.04M and $303.44M US Long portfolio, upped its stake in Royal Dutch Shell Plc by 64,156 shares to 91,264 shares, valued at $5.29M in 2016Q4, according to the filing.

Investors wait CVS Health Corp (NYSE:CVS) to report on November, 14. its quarterly earnings Wall Street analysts expect $1.49 EPS, down $0.15 or 9.15 % from last year’s $1.64 same quarter earnings. This translates into $1.51 billion profit for CVS giving the stock a 13.95 P/E. This is assuming the current $1.49 EPS is accurate. CVS Health Corp’s Wall Street analysts see 12.03 % EPS growth, taking into account the $1.33 EPS reproted in the previous quarter,

More notable recent CVS Health Corp (NYSE:CVS) news were published by: which released: “CareFirst BCBS re-ups with CVS Caremark” on September 05, 2017, also with their article: “CVS Health Gains on Pharmacy Services, Retail Remains a Drag” published on September 13, 2017, published: “Rikoon Group, LLC Buys SPDR S&P Dividend, CVS Health Corp, Accenture PLC …” on August 18, 2017. More interesting news about CVS Health Corp (NYSE:CVS) were released by: and their article: “CVS Health hiring 200 in Pittsburgh” published on September 08, 2017 as well as‘s news article titled: “CVS Health Hopes Partnerships Will Power Growth” with publication date: August 22, 2017.

CVS Health Corp (NYSE:CVS) Ratings Coverage

Among 23 analysts covering CVS Health (NYSE:CVS), 13 have Buy rating, 0 Sell and 10 Hold. Therefore 57% are positive. CVS Health has $132 highest and $77 lowest target. $103.44’s average target is 24.37% above currents $83.17 stock price. CVS Health had 39 analyst reports since July 22, 2015 according to SRatingsIntel. The stock of CVS Health Corp (NYSE:CVS) has “Neutral” rating given on Monday, May 9 by Citigroup. The company was maintained on Monday, November 2 by JP Morgan. Cowen & Co maintained CVS Health Corp (NYSE:CVS) on Tuesday, June 13 with “Buy” rating. Evercore reinitiated the shares of CVS in report on Wednesday, August 19 with “Buy” rating. The stock has “Outperform” rating by RBC Capital Markets on Wednesday, August 5. The firm earned “Neutral” rating on Thursday, February 2 by Robert W. Baird. Mizuho maintained the stock with “Buy” rating in Wednesday, November 9 report. Jefferies downgraded CVS Health Corp (NYSE:CVS) on Monday, December 12 to “Hold” rating. The firm has “Buy” rating by Jefferies given on Thursday, May 12. Vetr upgraded CVS Health Corp (NYSE:CVS) rating on Monday, August 24. Vetr has “Buy” rating and $117.98 target.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.